Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/22137
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWong, Jonathan-
dc.contributor.authorCher, Lawrence M-
dc.contributor.authorGriffiths, James-
dc.contributor.authorCohen, Aileen-
dc.contributor.authorHuang, Jane-
dc.contributor.authorWang, Lai-
dc.contributor.authorGregory, Gareth-
dc.contributor.authorOpat, Stephen-
dc.date2018-
dc.date.accessioned2019-12-04T01:53:26Z-
dc.date.available2019-12-04T01:53:26Z-
dc.date.issued2018-12-
dc.identifier.citationHemaSphere 2018; 2(6): e155-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/22137-
dc.language.isoeng-
dc.titleEfficacy of Zanubrutinib in the Treatment of Bing-Neel Syndrome.-
dc.typeJournal Article-
dc.identifier.journaltitleHemaSphere-
dc.identifier.affiliationDepartment of Hematology, Monash Health, Clayton, Victoria, Australia-
dc.identifier.affiliationMonash University, Clayton, Victoria, Australia-
dc.identifier.affiliationOlivia Newton-John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Victoria, Australia-
dc.identifier.affiliationBeiGene Company Ltd, San Mateo, CA, USA-
dc.identifier.doi10.1097/HS9.0000000000000155-
dc.identifier.pubmedid31723793-
dc.type.austinCase Reports-
local.name.researcherCher, Lawrence M
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.cerifentitytypePublications-
crisitem.author.deptMedical Oncology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

30
checked on Dec 21, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.